Valuation16 Feb 2026 13:09
Included within that very interesting Savills research note and which caught my eye was section:
In November 2025, Blue Owl Capital was reported to be in talks to acquire a 12-asset UK private hospital real estate portfolio, operated by Spire Healthcare under long leases, from Malaysia’s Employees Provident Fund (EPF), in a potential c. £1.3 billion transaction. While the transaction was reported as targeting completion before year-end, it has not been publicly confirmed as closed. If executed, the transaction would mark Blue Owl Capital's entry into UK healthcare real estate.
What does that potentially value the "entire" Estate at plus there is the operating company. As well as we know, Blue Owl Capital may still be looking at lodging a bid.
We may just be in for quite a surprise on the upside as to valuation.
I have never understood why major shareholders would be at all intereted in £2.50 to £3 a share. They typically seek multiples and these levels are only broadly in line with current broker forecasts. Blue Owl could buy the entire Estate for that !
As much as they may wish to sell, they are not distressed and will not leave anything on the table that they don't have to. They view the company as being significantly undervalued by the market thus demanding an alternative strategy to realise this value. They will not be interested in valaution levels in line with broker SP forecasts.